Financials in USD. Standardized financial statements.
A compact view of how 4D Molecular Therapeutics, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $85.21M | $37,000 | $20.72M | $3.13M | $18.04M | $13.61M | $6.99M | $14.13M | $5.79M |
| Revenue Growth? | +230194.6% | -99.8% | +562.3% | -82.7% | +32.5% | +94.8% | -50.6% | +144.0% | 0.0% |
| Cost of Revenue? | $7.63M | $0 | $97.10M | $80.25M | $61.36M | $53.04M | $38.72M | $18.36M | $13.57M |
| Gross Profit? | $77.58M | $37,000 | -$76.37M | -$77.12M | -$43.32M | -$39.43M | -$31.73M | -$4.23M | -$7.78M |
| Gross Margin? | +91.1% | +100.0% | -368.5% | -2464.8% | -240.2% | -289.6% | -454.2% | -30.0% | -134.4% |
| Operating Expenses? | $237.13M | $187.88M | $36.49M | $32.91M | $28.01M | $17.24M | $19.03M | $24.53M | $17.06M |
| Operating Income? | -$159.55M | -$187.84M | -$112.87M | -$110.03M | -$71.33M | -$56.66M | -$50.76M | -$10.40M | -$11.27M |
| EBITDA? | -$151.92M | -$181.14M | -$108.66M | -$107.63M | -$69.81M | -$55.22M | -$44.62M | -$9.70M | -$10.65M |
| Income Before Tax | -$140.11M | -$160.87M | -$100.84M | -$107.49M | -$71.32M | -$56.69M | -$49.31M | -$9.55M | -$11.22M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$89,000 |
| Net Income? | -$140.11M | -$160.87M | -$100.84M | -$107.49M | -$71.32M | -$56.69M | -$49.31M | -$9.55M | -$11.22M |
| EPS? | $-2.42 | $-2.98 | $-2.58 | $-3.12 | $-2.46 | $-2.12 | $-2.00 | $-0.76 | $-0.76 |
| Diluted EPS? | $-2.42 | $-2.98 | $-2.58 | $-3.12 | $-2.46 | $-2.12 | $-2.00 | $-0.76 | $-0.76 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality